The Holy Grail In Cancer? FDA Mulls New Blood Tests.

Grail stock was halted Wednesday as a Food and Drug Administration panel discussed the company's blood screening test for cancer. The post The Holy Grail In Cancer? FDA Mulls New Blood Tests. appeared first on Investor's Business Daily.